Nrf2 在衰老、阿尔茨海默病和其他神经退行性疾病中的作用。
Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
机构信息
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Department of Biological Science, College of Engineering and Natural Sciences, Tulsa, OK 74104, USA.
出版信息
Ageing Res Rev. 2022 Dec;82:101756. doi: 10.1016/j.arr.2022.101756. Epub 2022 Oct 13.
Nuclear Factor-Erythroid Factor 2 (Nrf2) is an important transcription factor that regulates the expression of large number of genes in healthy and disease states. Nrf2 is made up of 605 amino acids and contains 7 conserved regions known as Nrf2-ECH homology domains. Nrf2 regulates the expression of several key components of oxidative stress, mitochondrial biogenesis, mitophagy, autophagy and mitochondrial function in all organs of the human body, in the peripheral and central nervous systems. Mounting evidence also suggests that altered expression of Nrf2 is largely involved in aging, neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's diseases, Amyotrophic lateral sclerosis, Stroke, Multiple sclerosis and others. The purpose of this article is to detail the essential role of Nrf2 in oxidative stress, antioxidative defense, detoxification, inflammatory responses, transcription factors, proteasomal and autophagic/mitophagic degradation, and metabolism in aging and neurodegenerative diseases. This article also highlights the Nrf2 structural and functional activities in healthy and disease states, and also discusses the current status of Nrf2 research and therapeutic strategies to treat aging and neurodegenerative diseases.
核因子红细胞 2(Nrf2)是一种重要的转录因子,可调节健康和疾病状态下大量基因的表达。Nrf2 由 605 个氨基酸组成,包含 7 个保守区域,称为 Nrf2-ECH 同源结构域。Nrf2 调节氧化应激、线粒体生物发生、线粒体自噬、自噬和人体所有器官、外周和中枢神经系统中线粒体功能的几个关键组成部分的表达。越来越多的证据表明,Nrf2 的表达改变在很大程度上与衰老、神经退行性疾病有关,包括阿尔茨海默病、帕金森病、亨廷顿病、肌萎缩侧索硬化症、中风、多发性硬化症等。本文的目的是详细描述 Nrf2 在氧化应激、抗氧化防御、解毒、炎症反应、转录因子、蛋白酶体和自噬/线粒体自噬降解以及衰老和神经退行性疾病中的代谢中的重要作用。本文还强调了 Nrf2 在健康和疾病状态下的结构和功能活性,并讨论了 Nrf2 研究和治疗衰老和神经退行性疾病的治疗策略的现状。